Genome-wise association studies have identified a number of common single-nucleotide polymorphisms (SNPs), each of small effect, associated with risk to bipolar disorder (BD).
Introduction
Bipolar Disorder (BD) is a complex disorder characterized by mood dysregulation resulting in significant psychosocial impairment (van der Voort et al., 2015) . Family, twin, adoption and genome-wide association (GWAS) studies have consistently shown a substantial genetic contribution to disease etiology (Smoller and Finn, 2003; Alsabban et al., 2011) with heritability estimates ranging from 0.6 to 0.8 (Smoller and Finn, 2003; Lichtenstein et al. 2009 ). It is widely acknowledged that the genetic architecture of the BD is polygenic and consistent with a threshold-liability model (Gottesman and Shields, 1997) . Candidate gene and GWAS genetic studies have identified a number of single-nucleotide polymorphisms (SNPs) that are associated with increased risk for BD (International Schizophrenia Consortium, 2009; Psychiatric GWAS Consortium Bipolar Disorder Working Group, 2011; Green et al., 2013) . Individual risk-alleles for BD have been shown to influence brain structure and function in healthy individuals (Kempton et al., 2009; Bigos et al., 2010; Erk et al., 2010; Franke et al., 2010; Krug et al., 2010; Wessa et al., 2010; Heinrich et al., 2013; Paulus et al., 2014) , patients with BD (Mechelli et al., 2008; Perrier et al., 2011; Chakirova et al., 2011; Prata et al., 2011; Soeiro-de-Souza et al., 2012; Dima et al., 2013; Tesli et al., 2013) and their unaffected relatives (Lelli-Chiesa et al., 2008; Jogia et al., 2011; Whalley et al. 2012; Erk et al., 2014; Delvecchio et al., 2015) . Collectively, these studies have established that risk-variants for BD are linked to brain alterations considered relevant to the pathophysiology of the disorder. For example, meta-analyses of functional magnetic resonance imaging (fMRI) studies have consistently shown increased activation in the amygdala and decreased activation in the ventrolateral prefrontal cortex (vlPFC) across a number of cognitive tasks in patients with BD compared to healthy controls (Chen et al., 2011; Delvecchio et al., 2011) . Similarly, GWAS-supported risk-alleles in the CACNA1C and ANK3 genes, have been independently associated with increased amygdalar activity in patients with BD (Dima et al., 2013; Jogia et al., 2011) and in the vlPFC . However, individual GWAS-supported genetic loci only account for a very small fraction of the risk of BD (Visscher et al., 2012) . In response, the polygenic risk (PGR) score method has been developed to quantify the extent to which common risk-variants may collectively capture variation in susceptibility to disease (International Schizophrenia Consortium, 2009 ).
The PGR score for BD (PGR-BD) is calculated in each individual by aggregating variation across GWAS loci nominally associated with BD into a quantitative score (International Schizophrenia Consortium, 2009; Dima and Breen, 2015) , with the current PGR-BD explaining ~5% of the variance to BD (Cross-Disorder Group of the Psychiatric Genomics
Consortium, 2013). Two previous studies have used the polygenic risk score method to examine the cumulative impact of BD-related risk-conferring SNPs on task-related brain activation during an emotional processing (Tesli et al., 2015 ) and a word generation task (Whalley et al., 2012) . During emotional processing, a positive association was found in patients with BD and in controls between PRG-BD score and brain activation in the right vlPFC. In the word generation task a positive association was also present between the PGR-BD score and amydgalar activation in unaffected relatives of patients and in controls.
Neither study found an interaction between PGR-BD score and diagnostic group on the patterns of brain activation. This evidence collectively suggests that the influence of common risk-alleles on brain function may be more informative with regards to brain phenotypes related to vulnerability to BD rather than overt disease. The PGR method has a relatively higher explanatory power compared to single SNP examinations (Dima and Breen, 2015) , and may be useful in identifying regions where the additive effect of common risk-alleles converges to confer vulnerability to BD.
Based on the above we examined the effect of a PGR-BD on brain fMRI data from patients with BD, unaffected relatives and unrelated healthy controls while performing a facial affect and a working memory processing task. Current models of BD emphasise increased neural response to affective stimuli coupled with reduced efficacy of the neural systems responsible for cognitive control (Phillips et al., 2003; Cerullo et al., 2009) . We therefore chose the facial affect and working memory tasks as the former maps onto the ventral PFC-limbic pathway (Dima et al., 2011; Vuilleumier and Pourtois, 2007) implicated in the ability to process the emotional significance of stimuli and the later engages frontoparietal regions involved in cognitive control (Dima et al., 2014; Niendam et al., 2012; Owen et al., 2005) . Additionally, previous studies have reported brain functional abnormalities in patients with BD while performing these tasks (Cerullo et al., 2009 ) thus demonstrating their relevance to BD.
Using two different paradigms on the same study sample we aimed to test whether the polygenic load for BD has a localized effect to a region or a network of regions that are task dependent and may represent a common pathway linking genetic risk to BD-related brain abnormalities.
Material and Methods

Participants
Euthymic patients with BD (n = 41), their unaffected first-degree relatives (n = 25) and demographically matched unrelated healthy individuals (n = 46) were selected from the VIBES study (Frangou, 2009) (Table 1 ). All participants were of white British ancestry. They were assessed using the structured clinical interview for the Diagnostic and Statistical
Manual of Mental Disorders, 4th edition, revised (DSM-IV) for Axis I diagnoses (First et al., 2002a; 2002b) . Patients that fulfilled the criteria for BD, type I according to the DSM-IV (APA, 1994) were included. The relatives were carefully selected from the VIBES sample based on the absence of any lifetime history of psychopathology. The sample included 17
BD patients-sibling pairs from 17 different families. Unrelated healthy individuals were selected based on the absence of family history and personal lifetime history of psychiatric disorders. In all participants, current IQ was assessed using the Wechsler Adult Intelligence Scale 3rd Edition (Wechsler, 1997) and psychopathology was rated using the Hamilton Depression Rating Scale (Hamilton et al., 1960 ) (HDRS), Young Mania Rating Scale (Young et al., 1978) (YMRS) and Brief Psychiatric Rating Scale (Lukoff et al., 1986 ) (BPRS).
Psychopathology was assessed weekly in patients over a period of 1 month prior to testing and at each assessment they scored below 7 in the HDRS and YMRS. Patients were also required to have remained on the same type and dose of medication for a minimum of 6 months. The BPRS, HDRS and YMRS scores were highly correlated (all r > 0.73, p < 0.0001). To avoid collinearity we used the total BPRS score as a covariate in subsequent neuroimaging analyses because, unlike the two other scales, it is applicable to nonclinical populations.
DNA extraction and genotyping
We obtained DNA from the participants using buccal swabs and conventional procedures.
All participants were genotyped on the Psych Chip (Illumina Infinium PsychArray-24). Data quality was controlled in PLINK v1.07 (Purcell et al., 2007) using the same parameters as described in Coleman et al. (2015) . SNPs were excluded when missingness > 1%, minor allele frequency (MAF) < 0.01 or Hardy-Weinberg equilibrium (HWE) < 0.00001 and participants were excluded when missingness > 1%. Sex and relatedness checks were carried out, in addition to principal component analyses to confirm self-reported ethnicities (Patterson et al. 2006) .
Polygenic risk scores
Genome-wide polygenic risk scores for BD (PGR-BD) were generated with the PRSice software (http://prsice.info/; Euesden et al., 2015) using the most recent Psychiatric
Genomics Consortium (PGC) GWAS of BD from the cross disorder study (Cross-Disorder
Group of the Psychiatric Genomics Consortium, 2013). The SNPs used were those selected by the analysts of those studies using P-value-informed clumping in PLINK with a cut-off of 
Facial affect recognition paradigm
Three negative facial emotions (fear, anger and sadness) were examined in three eventrelated experiments presented in a random order during a single acquisition session. In each experiment, 10 different facial identities (www.paulekman.com) depicting 150% intensity of an affective or a neutral facial expression were presented in a pseudorandom order interspersed with a fixation cross. Each stimulus (affect and neutral faces; fixation cross) was displayed for 2s and repeated 20 times. Participants were instructed to indicate whether the face was emotional or neutral. Response time and accuracy data were collected.
Working memory paradigm
The 2-back task was presented as an alternating block paradigm incorporating the active (2-back) and baseline (0-back) conditions. Participants were instructed to respond to target letters by button press. In the baseline condition, participants responded to the X letter. In the 2-back condition participants responded when the letter presented matched the one in the preceding 2 trials. Each stimulus was presented for 2s. There were 18 epochs in all, each lasting 30s. Response time and accuracy data were collected.
Image acquisition
Anatomical and functional imaging data were acquired during the same session using a General Electric Sigma 1.5 Tesla. A high-resolution T1-weighted structural image was acquired for each participant in the same session in the axial plane for co-registration 
Functional Neuroimaging Data Analysis
Data were analysed in SPM8 (www.fil.ion.ucl.ac.uk/spm/software/spm8/). Data from each paradigm were analysed separately. For both paradigms, fMRI images were realigned, normalized and smoothed using an 8-mm full-width-half maximum Gaussian kernel. 
Effect of PGR-BD score on task-related activation
For each task separately, contrast images from each participant were entered into secondlevel analyses using one-sample t-tests to identify clusters of increased task-related activation at p < 0.05 with Family Wise Error (FWE) correction and cluster size (k) > 20. The BPRS total score and relatedness were added as covariates. Beta value from the suprathreshold clusters were then extracted using the eigenvariate function in SPM8 and entered into a multivariate model to examine the effect of PGR-BD and its interaction with group (BD patients, unaffected relatives, unrelated healthy controls) in SPSS22, with relatedness as a covariate.
Effect of PGR-BD score on group differences on task-related activation
The effect of group (patients, relatives controls) was examined separately for each paradigm (affect faces > neutral faces; 2-back > baseline) using a general lineal model in SMP8 with the BPRS total score as covariate. In each of these analyses, supra-threshold clusters signifying group differences were identified using FWE correction of p < 0.05, k > 20. Beta values were extracted from each supra-threshold cluster using the eigenvariate function in SPM8. To test whether the PGR-BD score explained additional variance in group differences, Pearson's correlation analyses were used to examine the relationship between mean signal change in the suprathreshold clusters and PGR-BD score in SPSS22, with relatedness as a covariate.
Results
Polygenic risk scores
We used one-way analysis of variance to compare patients, relatives, controls on PGR-BD scores derived using seven statistical thresholds (i.e., using SNPs with p-values less than 0.001, 0.05, 0.1, 0.2, 0.3, 0.4 and 0.5). Although the effect of group was significant at all thresholds, the highest difference (F = 5.94, p = 0.004) was found for the PGR-BD score using 16,691 SNPs with p < 0.1. This PGR-BD score was higher in patients than controls (p = 0.002) while in relatives it was numerically intermediated between that of patients (p = 0.06) and controls (p = 0.09) ( Table 1 ). All subsequent analyses and results refer to this PGR-BD score. In the patient group, no significant correlations were found between PGR-BD and symptom severity (based on the total score of the HDRS, YMRS and BPRS), age of onset, duration of illness, and number of depressive and manic episodes (p > 0.27).
Behavioural task performance
Details of task performance are shown in Table 1 . Patients' medication type and dose did not correlate with performance on either task (all p > 0.40). In the facial affect recognition paradigm, we found a main effect of group on response time (p = 0.004), with BD patients being slower than the other two groups (p < 0.007). However, the PGR-BD score showed a significant negative correlation with response time to affect compared to neutral faces when controlling for group (r = -0.31, p = 0.003). In the 2-back task, there was no effect of group and no significant correlations were found between PGR-BD score and task performance.
Effect of PGR-BD on task-related activation
Facial Affect Recognition: In all participants, activation in the affect > neutral faces contrast was found in the visual association and prefrontal cortical areas (Supplemental Table 1 ; Figure 1A ). There was a main effect of PGR-BD score (F = 2.03, p = 0.04) but no group by PGR-BD interaction (F = 0.99, p = 0.46). The PGR-BD score influenced mean signal change in the visual cortex (peak MNI coordinates at: x = -32, y = -88, z = 2; p = 0.006) ( Figure 1B ).
Working Memory: In all participants, activation in 2-back > baseline contrast was found in the ventral and dorsal lateral prefrontal cortex and in the parietal cortex (Supplemental Table 1 ; Figure 2A ). There was a main effect of PGR-BD score (F = 2.83, p = 0.01) but no group by PGR-BD interaction (F = 1.13, p = 0.33). The PGR-BD score influenced mean signal change in medial prefrontal cortex (peak MNI coordinates at: x = 22, y = 48, z = -14; p = 0.004) ( Figure 2B ).
Effect of PGR-BD on group differences on task-related activation
Facial Affect Recognition: In the contrast affect > neutral faces, an effect of group noted in the anterior cingulate cortex (ACC) and right superior frontal gyrus, where BD patients showed, respectively, increased and decreased activation compared to their relatives and unrelated healthy individuals (Supplemental Table 2 ). No significant correlation between the PGR-BD score and signal change in the suprathreshold clusters was identified (p>0.05).
Working Memory: No effect of group was noted in the 2-back > baseline contrast.
Discussion
The current study examined the cumulative impact of common risk-alleles for BD, expressed as a polygenic risk score (PGR-BD), on brain activation during facial affect and working memory processing in patients with BD, unaffected relatives and unrelated controls. As expected, the PGR-BD score was higher in BD patients. Relatives had intermediate values that were not statistically different from that of either patients or controls. In line with previous reports (Whalley et al., 2012; Tesli et al., 2015) , there was a significant effect of PGR-BD on task-related BOLD signal change independent of group but no significant PGR-BD score by group interactions. The current findings therefore support the notion that the polygenic load method is more informative in terms of identifying patterns of neural activation that mediate vulnerability to BD rather than symptom expression. This is consistent with the liabilitythreshold model of BD since a significant number of risk-alleles are also present in healthy individuals that are unlikely to ever develop BD. Our results also suggest that the effect of polygenic load for BD is not localised to a single region or pathway, irrespective of task.
Instead we found that the PGR-BD score influenced task-dependent brain activation.
During the facial affect recognition task, we found a negative association between the PGR-BD score and activation in the visual association cortex. This region is part of the ventral visual pathway, which together with the amygdala and ventral prefrontal regions, form the core facial affect processing network (Dima et al., 2011; Vuilleumier and Pourtois, 2007) .
Reduced visual cortical activation and connectivity during facial affect processing (Pavuluri et al., 2007; Dima et al., 2016) has been previously reported in patients with BD and have been consistently coupled with increased amygdalar and decreased vlPFC activation (Chen et al., 2011; Delvecchio et al., 2011) . Studies of single SNPs on brain function during emotional processing have found risk-variants to be related to increased amygdalar activation Dima et al., 2013; Tesli et al., 2013) . However, when considering thousands of risk-conferring alleles, as reflected in the PGR-BD score, we found that their additive effect on the facial affect network involved primarily the recruitment of visual cortical regions. These findings add to the growing evidence of visual information processing abnormalities in patients with BD observed in visual backward masking (McClure, 1999 ), vernier acuity (Keri et al., 2005 , motion discrimination (Chen et al., 2006; O'Bryan et al., 2014) , context modulation (Yang et al., 2013) and early visual evoked potentials (Yeap et al., 2009) . It is suggested therefore that abnormalities in early sensory processing of affective visual stimuli may contribute to inadequate emotional regulation and predispose individuals to development of the BD.
In the 2-back task, we found a positive association between the PGR-BD score and activation in the ventromedial prefrontal cortex (vmPFC), a brain region integral to the Default Mode Network (DMN), whose activity represents emotional processing during the default state Raichle et al., 2001) . Typically, vmPFC activation is reduced during cognitively demanding task consistent with the fact that such tasks attenuate emotional processing ). Failure to deactivate this region has been repeatedly reported in patients with BD both during acute episodes (Pomarol-Clotet et al., 2012; Fernandez-Corcuera et al., 2013) and during remission (Pomarol-Clotet et al., 2015) .
Similar abnormalities in the deactivation of the vmPFC have also been reported in unaffected relatives of patients (Thermenos et al., 2010; Alonso-Lana et al., 2016) and have been previously linked to risk-variants in the ANK3 gene (Delvecchio et al., 2015) . Our findings further confirm that abnormalities in suppressing vmPFC activation are likely to represent a genetically mediated vulnerability trait for BD that is linked to greater polygenic load for the disorder.
The main limitation of the current study relates to the sample size which is relatively small for the purposes of genetic studies and could be a potential reason why we did not find any significant group by PGR-BD interaction. On the other hand, the main advantage of the polygenic risk score method is that it provides a quantitative measure of the polygenic load of each study participant without relying on their genetic distance from an affected proband.
Moreover, the PGR-BD allows modelling the cumulative effect of multiple risk-variants for BD and is known to explain a greater proportion of phenotypic variance that single riks-alleles (International Schizophrenia Consortium, 2009; Dima and Green, 2015) .
In conclusion, we demonstrated that the polygenic risk architecture of BD influences the function of regions known to be involved in the sensory and default state processing of Association between polygenic risk score for bipolar disorder and activation in the ventromedial prefrontal cortex.
